Participants with Mild to Moderate Hidradenitis Suppurativa Will Receive EVO101 a Topical Cream 0.1%

Clinical trial NCT06645821 · RECRUITING

Trial details

NCT number: NCT06645821
Sponsor: Virginia Clinical Research, Inc.
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Hidradenitis Suppurativa (HS)

Start date: 2024-12-03
Primary completion: 2025-03-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.